We are proud to be part of Danaher Corporation, a global community of 63,000+ associates innovating at the #speedoflife to improve human health. Discover Danaher’s impact: https://bit.ly/46L6DxN Learn more about Danaher Life Sciences: https://bit.ly/4lamFXV Abcam, Aldevron, Beckman Coulter Life Sciences, Genedata, IDBS, Integrated DNA Technologies, Leica Microsystems, Molecular Devices, Phenomenex, SCIEX
Danaher Life Sciences
Pesquisa biotecnológica
Framingham, Massachusetts 37.216 seguidores
Innovation at the speed of life
Sobre nós
The Life Sciences companies of Danaher integrate the deep scientific expertise of our individual operating companies with the robust engineering know-how of the Danaher Business System to create innovative workflows that significantly bend the drug development time curve. Every day, scientists around the world are working to understand the causes of disease, develop new therapies and vaccines, and test new drugs. These life science companies make this leading-edge scientific research possible. Our capabilities extend beyond research to power the creation of biopharmaceuticals, cell and gene therapies, and other breakthrough treatments to advance patient health and improve treatment outcomes. Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life. Our global teams are pioneering what’s next across Life Sciences, Diagnostics, Biotechnology and beyond.
- Site
-
https://lifesciences.danaher.com
Link externo para Danaher Life Sciences
- Setor
- Pesquisa biotecnológica
- Tamanho da empresa
- + de 10.001 funcionários
- Sede
- Framingham, Massachusetts
- Tipo
- Empresa de capital aberto
Atualizações
-
In a recent webinar, Wayne Stallaert, Ph.D. shared a case study on how Leica Microsystems Cell DIVE platform and Abcam's antibody portfolio enable scalable, automated cell cycle mapping to extract rich single-cell data across large tissue microarrays. This approach helps uncover the mechanistic and molecular differences driving cancer cell proliferation. Read the article: https://bit.ly/4nio6Vm
-
AAV-based therapeutics hold enormous promise, but the cost and complexity of development remain significant barriers. By rethinking workflows, adopting scalable solutions, and improving data continuity, labs can make development more efficient and cost-effective without compromising quality. This blog explores how smarter, more connected approaches are advancing the development of AAV therapies. Read the blog: https://bit.ly/4p3jq6G Learn more about our Analytical Solutions: https://bit.ly/4g8zGj4
-
We accelerate the journey from discovery to therapy with solutions that enhance data accuracy, streamline workflows, and enable advanced R&D. By transforming scientific insights into actionable outcomes, our portfolio drives innovation in healthcare and supports healthier lives. Discover how Abcam, Aldevron, Beckman Coulter Life Sciences, Genedata, IDBS, Integrated DNA Technologies, Leica Microsystems, Molecular Devices, Phenomenex, and SCIEX are shaping the future of therapeutics: https://bit.ly/3V1bTb2
-
Smart analytics are transforming cell line development, making it faster, smarter, and more reliable. We see multiple ways to accelerate the CLD process: » Identifying high producers in <15 minutes. » Fully characterize intact proteins 95% faster. » Speed up clone picking process by 8X and reduce waste by 50%. These innovations help you select optimal cell lines faster, improve quality control, and move therapies forward with confidence. Read the blog: https://bit.ly/429nvNd
-
Join us at Festival of Biologics Europe, Booth 502. Meet experts from Genedata, Molecular Devices, Phenomenex, and SCIEX to explore how imaging, automation, analytics, AI and digital solutions can drive efficiency and accelerate your biotherapeutic journey from discovery to commercialization. Let's plan to connect: https://bit.ly/4nmtPc2
-
-
Scaling viral vector production brings persistent challenges from variability in quality to bottlenecks in process development. Meeting these demands requires integrated solutions that connect analytics, automation and digital workflows. This blog highlights how we are helping gene therapy programs streamline development, improve consistency and scale with confidence. Read the blog: https://bit.ly/41w5uIs Learn more about our Analytical Solutions: https://bit.ly/4g8zGj4
-
We accelerate the path from discovery to therapy with solutions that improve data accuracy, streamline workflows, and scale advanced models. Our portfolio turns scientific insights into real impact, driving progress in healthcare and improving lives. Learn how Abcam, Aldevron, Beckman Coulter Life Sciences, Genedata, IDBS, Integrated DNA Technologies, Leica Microsystems, Molecular Devices, Phenomenex, and SCIEX are shaping the future of therapeutics: https://bit.ly/3V1bTb2
-
As ADCs evolve, so do the analytical demands. From impurities to PTMs and payloads, researchers face rising complexity, longer development cycles, and higher resource investments. Integrated approaches offer a path forward. Watch this webinar with Phenomenex and SCIEX to see how streamlined analytical solutions accelerate ADC development and deliver more reliable results. Watch Today: https://bit.ly/4mK57T3
-
Proteomic analysis provides critical insights, but manual sample preparation often slows progress and increases variability. Automating workflows and improving data continuity make analysis more efficient, reproducible, and scalable. This blog explores how connected approaches are advancing proteomics to accelerate discovery. Read the blog: https://bit.ly/4g2uFs9 Learn more about our Analytical Solutions: https://bit.ly/4g8zGj4